Patricia Oliver-Shaffer

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Vertex Pharmaceuticals, Inc., Forum Pharmaceuticals, Inc., Envivo Pharmaceuticals, Inc.. Active years: 2006-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patricia Oliver-Shaffer. Retrieved from https://idiyas.com/inventor/patricia-oliver-shaffer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 11.1

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 91(Granted Patents)

Company Filing History:

5 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

3 out of 9

Forum Pharmaceuticals, Inc.

patents

1 out of 13

Envivo Pharmaceuticals, Inc.

patents

Years Active: 2006-2017

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9550767 - Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate (2017-01-24),

2. 9273044 - Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate (2016-03-01),

3. 9108961 - Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride (2015-08-18),

4. 8710227 - Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate (2014-04-29),

5. 8686157 - Processes for the facile synthesis of diaryl amines and analogues thereof (2014-04-01),

6. 8426426 - Gyrase inhibitors and uses thereof (2013-04-23),

7. 8034950 - Processes for the facile synthesis of diaryl amines and analogues thereof (2011-10-11),

8. 7727992 - Gyrase inhibitors and uses thereof (2010-06-01),

9. 7115746 - Processes for the facile synthesis of diaryl amines and analogues thereof (2006-10-03),

Title: The Innovative Contributions of Patricia Oliver-Shaffer

Introduction

Patricia Oliver-Shaffer, a prolific inventor based in Acton, MA, has made significant strides in the field of pharmaceutical research and development. With a remarkable portfolio of nine patents, her work primarily focuses on the crystalline forms of potent compounds with therapeutic applications.

Latest Patents

Among her latest patents, Patricia has developed innovative crystalline formations for (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate. Specifically, her patents include Crystalline Forms I and II of this compound, which detail the compositions, methods of manufacture, and therapeutic uses thereof. These advancements hold promise for improving the efficacy of treatments in their respective medical fields.

Career Highlights

Throughout her career, Patricia has been associated with prominent pharmaceutical companies such as Vertex Pharmaceuticals, Inc. and Forum Pharmaceuticals, Inc. Her work in these organizations has allowed her to push the boundaries of innovation, contributing to the development of new therapeutic solutions.

Collaborations

In her research endeavors, Patricia has collaborated with esteemed colleagues, including Gideon Shapiro and Richard Chesworth. Their collective expertise has helped foster advancements in the pharmaceutical domain, showcasing the power of teamwork in innovation.

Conclusion

Patricia Oliver-Shaffer's contributions to the field of pharmaceuticals highlight her innovative spirit and dedication to enhancing therapeutic options. With her extensive patent portfolio and collaborative efforts, she continues to be a valuable asset to the scientific community. Her work exemplifies the impact of dedicated inventors in shaping the future of medicine.

Profile summary based on public USPTO records.